Details of the Drug
General Information of Drug (ID: DMCLAXG)
Drug Name |
2-benzyloxy-7,8-dihydro-6H-quinolin-5-one
|
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms |
CHEMBL400104; 2-benzyloxy-7,8-dihydro-6H-quinolin-5-one; SCHEMBL4275594; 2-(BENZYLOXY)-7,8-DIHYDROQUINOLIN-5(6H)-ONE; VGMBEUFDLPGOMH-UHFFFAOYSA-N; BDBM50231740; ZINC28967402; AB68928; 143232-64-8; 2-Benzyloxy-7,8-dihydroquinolin-5(6H)-one; 5,6,7,8-tetrahydro-2-(phenylmethoxy)-5-oxoquinoline; 5,6,7,8-Tetrahydro-5-oxo-2-(phenylmethoxy)quinoline
|
|||||||||||||||||||
Indication |
|
|||||||||||||||||||
Drug Type |
Small molecular drug
|
|||||||||||||||||||
Structure |
![]() |
|||||||||||||||||||
3D MOL | 2D MOL | |||||||||||||||||||
#Ro5 Violations (Lipinski): 0 | Molecular Weight (mw) | 253.29 | ||||||||||||||||||
Topological Polar Surface Area (xlogp) | 2.8 | |||||||||||||||||||
Rotatable Bond Count (rotbonds) | 3 | |||||||||||||||||||
Hydrogen Bond Donor Count (hbonddonor) | 0 | |||||||||||||||||||
Hydrogen Bond Acceptor Count (hbondacc) | 3 | |||||||||||||||||||
Chemical Identifiers |
|
|||||||||||||||||||
Cross-matching ID | ||||||||||||||||||||
Molecular Interaction Atlas of This Drug
![]() Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Discovery agent | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | N.A. | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||
References